Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MACULAR DEGENERATION - DRUG THERAPY , . Treffer: 10

2013

Krebs, I; Glittenberg, C; Ansari-Shahrezaei, S; Hagen, S; Steiner, I; Binder, S Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.
Br J Ophthalmol. 2013; 97(11):1443-1446
Web of Science PubMed FullText FullText_MUG

 

Krebs, I; Schmetterer, L; Boltz, A; Told, R; Vécsei-Marlovits, V; Egger, S; Schönherr, U; Haas, A; Ansari-Shahrezaei, S; Binder, S; MANTA Research Group A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration.
Br J Ophthalmol. 2013; 97(3):266-271
Web of Science PubMed FullText FullText_MUG

 

Krebs, I; Vécsei Marlovits, V; Bodenstorfer, J; Glittenberg, C; Ansari Shahrezaei, S; Ristl, R; Binder, S Comparison of Ranibizumab monotherapy versus combination of Ranibizumab with photodynamic therapy with neovascular age-related macular degeneration.
Acta Ophthalmol. 2013; 91(3):e178-e183 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Boltz, A; Ruiâ, M; Jonas, JB; Tao, Y; Rensch, F; Weger, M; Garhöfer, G; Frantal, S; El-Shabrawi, Y; Schmetterer, L Role of Vascular Endothelial Growth Factor Polymorphisms in the Treatment Success in Patients with Wet Age-related Macular Degeneration.
Ophthalmology. 2012; 119(8):1615-1620
Web of Science PubMed FullText FullText_MUG

 

Dunavoelgyi, R; Sacu, S; Eibenberger, K; Palkovits, S; Leydolt, C; Pruente, C; Schmidt-Erfurth, U Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
Retina. 2012; 32(8): 1471-1479.
Web of Science PubMed FullText FullText_MUG

 

2011

Ansari-Shahrezaei, S; Binder, S; Stur, M The effect of laser unit on photodynamic therapy spot size.
Graefes Arch Clin Exp Ophthalmol. 2011; 249(1):11-14
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schmid-Kubista, KE; Krebs, I; Ansari-Shahrezaei, S; Haas, P; Hagen, S; Binder, S Comparing treatment of neovascular age-related macular degeneration with sequential intravitreal Avastin and Macugen versus intravitreal mono-therapy--a pilot study.
Curr Eye Res. 2011; 36(10):958-963
Web of Science PubMed FullText FullText_MUG

 

2008

Wolf, A; Kook, D; Strauss, R; Kampik, A; Haritoglou, C How to treat recurrences after Avastin treatment for neovascular AMD: stick to Avastin or switch to Lucentis?
Br J Ophthalmol. 2008; 92(9):1298-1299
Web of Science PubMed FullText FullText_MUG

 

2006

Ergun, E; Maár, N; Ansari-Shahrezaei, S; Wimpissinger, B; Krepler, K; Wedrich, A; Stur, M Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Am J Ophthalmol. 2006; 142(1):10-16
Web of Science PubMed FullText FullText_MUG

 

Mozaffarieh, M; Wedrich, A Steroid therapy for exudative age-related macular degeneration: bridging the gap until a cure is found.
CURR OPIN INVESTIG DRUGS. 2006; 7(1): 18-19.
Web of Science PubMed

 

© Meduni Graz Impressum